Increased μ-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMC 4552652)

Published in PLoS One on August 28, 2015

Authors

Anna Mikosik1, Izabella Henc2, Katarzyna Ruckemann-Dziurdzińska2, Joanna E Frąckowiak1, Anna Płoszyńska3, Anna Balcerska3, Ewa Bryl2, Jacek M Witkowski1

Author Affiliations

1: Department of Pathophysiology, Medical University of Gdańsk, Gdańsk, Poland.
2: Department of Pathology and Experimental Rheumatology, Medical University of Gdańsk, Gdańsk, Poland.
3: Clinic of Pediatrics, Hematology and Oncology, Medical University of Gdańsk, Gdańsk, Poland.

Articles cited by this

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell (2002) 11.83

The calpain system. Physiol Rev (2003) 9.95

Mitochondrial control of cell death. Nat Med (2000) 9.17

Acute lymphoblastic leukaemia. Lancet (2008) 8.54

Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med (2009) 7.95

Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A (1991) 5.78

Calpain and caspase: can you tell the difference? Trends Neurosci (2000) 3.14

Regulating cell migration: calpains make the cut. J Cell Sci (2005) 3.03

Structure and physiological function of calpains. Biochem J (1997) 2.62

Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood (2000) 2.53

Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia. Blood (2000) 2.21

The calpain system and cancer. Nat Rev Cancer (2011) 2.10

New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat Rev Drug Discov (2007) 2.09

Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol (2013) 1.88

Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature (2008) 1.84

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia (1999) 1.83

Hypercalcemia in acute lymphoblastic leukemia: an overview. J Pediatr Hematol Oncol (2009) 1.76

Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias. Leukemia (2006) 1.41

Analysis of apoptosis by laser scanning cytometry. Cytometry (1999) 1.29

Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem (2000) 1.25

Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem (2006) 1.25

Calpain chronicle--an enzyme family under multidisciplinary characterization. Proc Jpn Acad Ser B Phys Biol Sci (2011) 1.21

Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ (1998) 1.17

Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc (2010) 1.15

Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells. J Exp Med (2005) 1.12

Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood (2006) 1.10

Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion. Genes Chromosomes Cancer (1999) 1.08

A NEUTRAL, CALCIUM-ACTIVATED PROTEINASE FROM THE SOLUBLE FRACTION OF RAT BRAIN. J Biol Chem (1964) 1.07

Characterization of the intracellular proteolytic cleavage of myocilin and identification of calpain II as a myocilin-processing protease. J Biol Chem (2007) 1.06

Improving outcomes for high-risk ALL: translating new discoveries into clinical care. Pediatr Blood Cancer (2011) 1.05

Calpains as potential anti-cancer targets. Expert Opin Ther Targets (2011) 1.05

Childhood cancer: cure at what cost? Arch Dis Child (1990) 1.02

Participation of the conventional calpains in apoptosis. Biochim Biophys Acta (2002) 0.97

Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia. Leuk Res (2004) 0.94

Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood (2002) 0.93

5q- anomaly in acute lymphoblastic leukemia. Cancer Genet Cytogenet (1992) 0.90

Biology of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol (2013) 0.89

Role of calpain in apoptosis. Cell J (2011) 0.89

Conventional calpains and programmed cell death. Acta Biochim Pol (2011) 0.89

Calpastatin subdomains A and C are activators of calpain. J Biol Chem (2002) 0.88

Attenuation of CXCR4 responses by CCL18 in acute lymphocytic leukemia B cells. J Cell Physiol (2010) 0.86

Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission. Br J Haematol (2013) 0.86

Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathway. Pharmacol Res (2003) 0.86

Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia. Br J Haematol (2009) 0.86

CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12. PLoS One (2014) 0.85

Secondary chromosomal abnormalities in acute leukemias. Leukemia (1994) 0.85

Calpastatin in erythrocytes of young and old individuals. Biochem J (1994) 0.84

Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome. Leuk Res (2002) 0.84

Calpain inhibitor II induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells as well as some solid tumor cells. Clin Cancer Res (2000) 0.83

Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression. J Biol Chem (2008) 0.83

Unexpected cytogenetic finding in acute lymphoblastic leukemia: a case of del(5q) with a cryptic t(12;21). Cancer Genet Cytogenet (2006) 0.82

Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation. Pediatr Blood Cancer (2008) 0.82

Spontaneous and cytokine-evoked production of matrix metalloproteinases by bone marrow and peripheral blood pre-B cells in childhood acute lymphoblastic leukaemia. Eur Cytokine Netw (2005) 0.81

The structure of calcium-free human m-calpain: implications for calcium activation and function. Trends Cardiovasc Med (2001) 0.81

Ex vivo measurement of calpain activation in human peripheral blood lymphocytes by detection of immunoreactive products of calpastatin degradation. Folia Histochem Cytobiol (2007) 0.81

Induction of apoptosis in Eμ-myc lymphoma cells in vitro and in vivo through calpain inhibition. Exp Hematol (2012) 0.80

A decisive role of mitochondria in defining rate and intensity of apoptosis induction by different alkaloids. Toxicol Lett (2008) 0.80

Cytometric evaluation of transferrin receptor 1 (CD71) in childhood acute lymphoblastic leukemia. Folia Histochem Cytobiol (2012) 0.78

Rapid communication: Nucleotide sequences of two isoforms of porcine micromolar calcium-activated neutral protease 1 cDNA. J Anim Sci (2001) 0.78

Expression of calpain-calpastatin system (CCS) member proteins in human lymphocytes of young and elderly individuals; pilot baseline data for the CALPACENT project. Immun Ageing (2013) 0.78

Severe hypercalcemia as a harbinger of acute lymphoblastic leukemia. Pediatr Emerg Care (2007) 0.77

Elevated calpain activity in acute myelogenous leukemia correlates with decreased calpastatin expression. Blood Cancer J (2012) 0.77

Proliferation and apoptosis in newly diagnosed and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (2000) 0.77